| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |